Literature DB >> 1980112

The induction of skin graft tolerance in major histocompatibility complex-mismatched or primed recipients: primed T cells can be tolerized in the periphery with anti-CD4 and anti-CD8 antibodies.

S P Cobbold1, G Martin, H Waldmann.   

Abstract

Mice given short courses of anti-CD4 and anti-CD8 monoclonal antibodies became tolerant of allogeneic skin grafted at the same time. Tolerance could be obtained without T cell depletion across multiple minor antigen mismatches, both in naive and primed animals, demonstrating that peripheral T cells could be tolerized, even if they had been previously activated. Where donor and recipient were incompatible across the whole major histocompatibility complex, specific tolerance could be achieved by using a combination of depleting followed by non-depleting antibodies, where each alone was unsuccessful. Although mice clearly tolerated their original skin grafts, we observed in some strain combinations that a second fresh, but genotypically identical graft, was slowly rejected. Such mice also possessed T cells which could proliferate to donor-type stimulator cells in vitro. Whatever the mechanisms, we have demonstrated that operational transplantation tolerance can be achieved with simple, non-toxic antibody therapy. The introduction of comparable tolerance-inducing regimens in clinical organ transplantation could obviate the need for long-term immunosuppression and its unfortunate side effects.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1980112     DOI: 10.1002/eji.1830201232

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  31 in total

1.  Prediction of graft prolongation by mixed lymphocyte culture following anti-CD4 monoclonal antibody treatment among different donor-recipient combinations.

Authors:  K Hamano; H Ito; B Shirasawa; H Gohra; T Katoh; Y Fujimura; K Esato
Journal:  Surg Today       Date:  1999       Impact factor: 2.549

Review 2.  Dominant regulation: a common mechanism of monoclonal antibody induced tolerance?

Authors:  K Honey; S P Cobbold; H Waldmann
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

3.  Co-receptor and co-stimulation blockade for mixed chimerism and tolerance without myelosuppressive conditioning.

Authors:  Luis Graca; Stephen Daley; Paul J Fairchild; Stephen P Cobbold; Herman Waldmann
Journal:  BMC Immunol       Date:  2006-04-25       Impact factor: 3.615

Review 4.  Immunotherapy of rheumatoid arthritis.

Authors:  R A Watts; J D Isaacs
Journal:  Ann Rheum Dis       Date:  1992-05       Impact factor: 19.103

5.  Contribution of TCR signaling strength to CD8+ T cell peripheral tolerance mechanisms.

Authors:  Trevor R F Smith; Gregory Verdeil; Kristi Marquardt; Linda A Sherman
Journal:  J Immunol       Date:  2014-08-25       Impact factor: 5.422

6.  Reshaping a therapeutic CD4 antibody.

Authors:  S D Gorman; M R Clark; E G Routledge; S P Cobbold; H Waldmann
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-15       Impact factor: 11.205

7.  CD8 blockade promotes the expansion of antigen-specific CD4+ FOXP3+ regulatory T cells in vivo.

Authors:  Z Wang; J D Davies
Journal:  Int Immunopharmacol       Date:  2006-11-28       Impact factor: 4.932

8.  Pharmacokinetics/pharmacodynamics of nondepleting anti-CD4 monoclonal antibody (TRX1) in healthy human volunteers.

Authors:  Chee M Ng; Eric Stefanich; Banmeet S Anand; Paul J Fielder; Louis Vaickus
Journal:  Pharm Res       Date:  2006-11-30       Impact factor: 4.200

Review 9.  Short term immunosuppressive therapy and long-term immunoregulation: promises and problems.

Authors:  J Isaacs; A Dick
Journal:  Br J Ophthalmol       Date:  1996-12       Impact factor: 4.638

10.  Effects of CD8 depletion on retinal soluble antigen induced experimental autoimmune uveoretinitis.

Authors:  V L Calder; Z S Zhao; Y Wang; K Barton; S L Lightman
Journal:  Immunology       Date:  1993-06       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.